- Home
- IOVA vs SIGIP Comparison
IOVA vs SIGIP Comparison
Compare IOVA & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IOVA | SIGIP |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IOVA | SIGIP |
|---|---|---|
| Price | $2.47 | $16.99 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $10.45 | N/A |
| AVG Volume (30 Days) | ★ 10.2M | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $250,425,000.00 | N/A |
| Revenue This Year | $60.94 | N/A |
| Revenue Next Year | $60.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 175.62 | N/A |
| 52 Week Low | $1.64 | N/A |
| 52 Week High | $8.15 | N/A |
Technical Indicators
Market Signals| Indicator | IOVA | SIGIP |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 36.83 |
| Support Level | $2.08 | $16.66 |
| Resistance Level | $2.32 | $16.83 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 73.08 | 18.92 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.